tiprankstipranks
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market
ENP
Tryptamine Therapeutics
RESEARCH TOOLSreports

Compare Tryptamine Therapeutics (ENP) vs. Competitors

15 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ENP
Tryptamine Therapeutics
―
AU$48.52M
-9.56
3.45%
―
xxxxxxxxxxxxx
ENP
xxxxxxxxxxxxx
ATX
Amplia Therapeutics
AU$0.14
AU$79.53M
-3.83
176.79%
―
xxxxxxxxxxxxx
ENP vs ATX
xxxxxxxxxxxxx
ACW
Actinogen Medical
AU$0.04
AU$136.48M
-4.28
35.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
xxxxxxxxxxxxx
ENP vs ACW
xxxxxxxxxxxxx
NEU
Neuren Pharmaceuticals Limited
AU$12.52
AU$1.58B
78.41
30.83%
6 Buy
0 Hold
0 Sell
Strong Buy
xxxxxxxxxxxxx
ENP vs NEU
xxxxxxxxxxxxx
ZLD
Zelira Therapeutics
AU$0.34
AU$5.95M
-1.39
6.38%
―
xxxxxxxxxxxxx
ENP vs ZLD
xxxxxxxxxxxxx
NSB
Neuroscientific Biopharmaceuticals Ltd.
AU$0.10
AU$33.26M
-5.38
185.71%
―
xxxxxxxxxxxxx
ENP vs NSB
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:ENP
Tryptamine Therapeutics
0.03
>-0.01
-9.09%
AU:ATX
Amplia Therapeutics
0.16
0.10
192.45%
AU:ACW
Actinogen Medical
0.04
<0.01
31.03%
AU:NEU
Neuren Pharmaceuticals Limited
12.52
1.39
12.49%
AU:ZLD
Zelira Therapeutics
0.50
0.09
21.95%
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.10
0.06
150.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
Compare More Stocks >